Barbara Tevelev is the Global Manager CMC Biologics at Pfizer Global Product Development, where they lead global regulatory strategies for biologics and author high-quality CMC documentation. With over 20 years of experience in global biologic project portfolios, they have previously held roles as a Senior Scientist in BioProcess R&D at Pfizer and as a Scientist in R&D at Wyeth. Currently, Barbara is also a PhD Candidate in Health Sciences, furthering their expertise in regulatory affairs and biologics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices